Cambridge-based digital health platform, PocDoc, has successfully raised an additional £2.5 million for its Seed round, bringing the total investment to £5 million. The extension round was led by existing investors Forward Partners and MMC Ventures, with Simplyhealth Ventures and notable angel investors joining the round. PocDoc has also appointed ex-Axa Healthcare CEO Keith Gibbs as Chair.
PocDoc aims to address a major global healthcare challenge by increasing access and accelerating treatment for patients without adding further burden onto clinicians. The company’s app-based technology platform combines proprietary lateral flow tests and cloud-based AI diagnostics to offer end-to-end digital pathways for the assessment, diagnosis, and treatment of major diseases, initially focusing on cardiovascular disease (CVD).
CVD is a leading cause of premature disability, mortality, and health inequalities in the UK, affecting 7.6 million people and accounting for one in four deaths annually, according to the British Heart Foundation. Access to full five-marker cholesterol testing is a significant barrier to diagnosing and treating CVD. PocDoc’s technology offers a complete cardiovascular health check pathway, including a lab-grade five-marker cholesterol test with results available on the app within 10 minutes per person.
The additional funding and support from high-profile investors are expected to aid PocDoc in expanding its presence in the UK and beyond over the next year.
